Wednesday, January 12, 2022 9:51:12 PM
Accesswire
January 11, 2022
https://finance.yahoo.com/news/gladstone-land-announces-increase-monthly-210500762.html
MCLEAN, VA / ACCESSWIRE / January 11, 2022 /Gladstone Land Corporation (Nasdaq:LAND) ("Gladstone Land" or the "Company") announced today that its board of directors declared the following cash distributions for each of January, February and March 2022.
Monthly Cash Distributions:
Common Stock: $0.0453 per share of common stock for each of January, February and March 2022, payable per the table below:
Summary of Common Stock Cash Distributions
Record Date
Payment Date
Amount
January 21
January 31
$ 0.0453
February 18
February 28
0.0453
March 23
March 31
0.0453
Total for the Quarter:
$ 0.1359
The Company has paid 107 consecutive monthly cash distributions on its common stock since its initial public offering in January 2013 and has increased its common stock distributions 25 times over the prior 28 quarters. The Company offers a dividend reinvestment plan (the "DRIP") to its common stockholders. For more information regarding the DRIP, please visit www.GladstoneLand.com.
Series B Preferred Stock(Nasdaq LANDO): $0.125 per share of Series B Preferred Stock for each of January, February and March 2022, payable per the table below:
Summary of Series B Preferred Stock Cash Distributions
Record Date
Payment Date
Amount
January 21
January 31
$ 0.125
February 18
February 28
0.125
March 23
March 31
0.125
Total for the Quarter:
$ 0.375
The Company has not skipped, reduced, or deferred a monthly Series B Preferred Stock distribution to date.
Series C Preferred Stock(Unlisted): $0.125 per share of Series C Preferred Stock for each of January, February and March 2022, payable per the table below:
Summary of Series C Preferred Stock Cash Distributions
Record Date
Payment Date
Amount
January 26
February 4
$ 0.125
February 24
March 4
0.125
March 25
April 4
0.125
Total for the Quarter:
$ 0.375
The Company has not skipped, reduced, or deferred a monthly Series C Preferred Stock distribution to date.
Series D Preferred Stock (Nasdaq:LANDM): $0.104167 per share of Series D Preferred Stock for each of January, February and March 2022, payable per the table below:
Summary of Series D Preferred Stock Cash Distributions
Record Date
Payment Date
Amount
January 21
January 31
$ 0.104167
February 18
February 28
0.104167
March 23
March 31
0.104167
Total for the Quarter:
$ 0.312501
The Company has not skipped, reduced, or deferred a monthly Series D Preferred Stock distribution to date.
Earnings Announcement:
The Company also announced today that it plans to report earnings for its fourth quarter ended December 31, 2021, after the stock market closes on Tuesday, February 22, 2022. The Company will hold a conference call on Wednesday, February 23, 2022, at 8:30 a.m. EST to discuss its earnings results. Please call (877) 407-9046 to join the conference call. An operator will monitor the call and set a queue for questions.
A conference call replay will be available after the call and will be accessible through March 2, 2022. To hear the replay, please dial (877) 660-6853 and use playback conference number 13725346.
The live audio broadcast of the Company's conference call will also be available online at www.GladstoneLand.com.
About Gladstone Land:
Gladstone Land is a publicly-traded real estate investment trust that invests in farmland located in major agricultural markets in the U.S., which it leases to farmers. The Company currently owns 164 farms, comprised of approximately 113,000 acres in 15 different states and 45,000 acre-feet of banked water in California, valued at approximately $1.5 billion, in the aggregate. Additional information can be found at www.GladstoneLand.com.
For stockholder information on Gladstone Land, call (703) 287-5893. For Investor Relations inquiries related to any of the monthly dividend-paying Gladstone funds, please visit www.GladstoneCompanies.com.
For further information: Gladstone Land Corporation, +1-703-287-5893
SOURCE: Gladstone Land Corporation
<<<
FEATURED NanoViricides Reports that the Phase I NV-387 Clinical Trial is Completed Successfully and Data Lock is Expected Soon • May 2, 2024 10:07 AM
ILUS Files Form 10-K and Provides Shareholder Update • ILUS • May 2, 2024 8:52 AM
Avant Technologies Names New CEO Following Acquisition of Healthcare Technology and Data Integration Firm • AVAI • May 2, 2024 8:00 AM
Bantec Engaged in a Letter of Intent to Acquire a Small New Jersey Based Manufacturing Company • BANT • May 1, 2024 10:00 AM
Cannabix Technologies to Deliver Breath Logix Alcohol Screening Device to Australia • BLO • Apr 30, 2024 8:53 AM
Hydromer, Inc. Reports Preliminary Unaudited Financial Results for First Quarter 2024 • HYDI • Apr 29, 2024 9:10 AM